- U.S. indexes lose slightly; US30 records deepest retreat, near 0.5%
- Medical robot and software provider Intuitive Surgical (ISRG.US) gains 7.5% on wave of Q2 year-end results; shares at historic highs
- Semiconductors under pressure again; Intel loses nearly -5%, TSMC near -3%
- Tesla records more than 2% sell-off; Comerica (CMA.US) and WR Berkley (WRB.US) stocks depreciate sharply
- Crowdstrike (CRWD.US) loses -10% as a result of global IT failure
The U.S. stock market is trading another weaker session today, although the scale of supply is relatively small at this point. Despite on that, US indices are on a way to weakest week since April. Netflix's results caused virtually no volatility on the currency; the stock is trading 0.7% lower. Semiconductors are still under pressure, with TSMC shares losing 1.8% despite yesterday's excellent Q2 results and higher forecasts, suggesting a potential at least temporary reversal of momentum from the chipmakers; Intel is also losing more than 3%. U.S. 10-year Treasury bond yields return above 4.2%
Most U.S. companies are down today; oil and gas, insurance, and semiconductors and software sectors are performing poorly. Shares of obesity drug makers Eli Lilly (LLY.US) and Novo Nordisk (NVO.US) are gaining. Source: xStation5
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appUS30 chart
Looking at the DJIA (US30) contracts, we see record selling since the last roll-off in June; the index has retreated below the key momentum averages SMA50 and SMA100 on the hourly interval and is struggling to hold support at the 38.2 Fibonacci retracement of the upward wave from early July, at 40700 points.
Source: xStation5
News from companies
- Hawaiian Electric Industries gains more than 30% as the company was among the companies that tentatively agreed to softer-than-expected contract terms to resolve litigation related to last year's Maui fire
- Comerica shares are losing more than 10% after the lender said it expects its full-year net interest income to fall 14% from a year earlier. The company also said it has received preliminary information that its banking unit will no longer act as agent for its Direct Express program, which had been bringing it additional profits
- Halliburton's shares lost nearly 7%, with the oilfield services company's second-quarter revenue falling short of expectations. According to J.P Morgan, the results were disappointingly weak, even more so given the company's dominance in the oil & gas services market
Robotics and AI - great results for Intuitive Surgical
Intuitive Surgical's (ISRG.US) results surprised Wall Street, with the company beating profit and revenue forecasts. Earnings per share came in at $1.78 against $1.54 forecasts; revenues also rose to $2.01 billion against expectations of $1.97 billion (a 14% year-on-year increase). Da Vinci robot operations grew 17% year over year, and the installed base of robots grew an impressive 14% year over year, suggesting a significant increase in business scale to more than 9200 globally installed robots. A further 341 robots were installed in Q2 alone, with 70 models, including the latest da Vinci 5. Operating profit rose to $754 million in the latest quarter from $618 million in Q2 2023. The company expects to maintain the growth rate.
Chart of Intuitive Surgical (ISRG.US, D1)
The stock is trading in a multi-year upward channel, but a correction scenario is not out of the question; key support will be found around $390 per share, where we see recent price reactions and the 23.6 Fibonacci retracement.
Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
